Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, results, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006).
In a group of 465 patients diagnosed as having chronic mercury toxicity (CMT), 32.3% had severe fatigue, 88.8% had memory loss, and 27.5% had depression. A significant correlation was found between CMT and the Apo-lipoprotein E4 genotype (p=0.001). An investigation into an additional 864 consecutively seen general practice patients, resulted in 30.3% having evidence consistent with CMT, and once again a significant correlation was found with the APO-E4 genotype (p=0.001). Removal of amalgam mercury fillings when combined with appropriate results resulted in a significant symptom reduction (p<0.001) to levels reported by healthy subjects.